eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Bayer plc

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 13/08/2010
PIL Magnevist

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/08/2010 and displayed until Current
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 17/12/2008 and displayed until 13/08/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 25/06/2008 and displayed until 17/12/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
  • Change to MA holder contact details
  • Change of licence holder
Updated on 18/09/2007 and displayed until 25/06/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 09/07/2007 and displayed until 18/09/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 16/12/2004 and displayed until 09/07/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 23/11/2001 and displayed until 16/12/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 13/09/2000 and displayed until 23/11/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   dimeglumine gadopentetate